Literature DB >> 28887276

Moyamoya Vasculopathy in PHACE Syndrome: Six New Cases and Review of the Literature.

Domenico Tortora1, Mariasavina Severino2, Andrea Accogli3, Carola Martinetti1, Nadia Vercellino4, Valeria Capra3, Andrea Rossi1, Marco Pavanello5.   

Abstract

BACKGROUND: PHACE syndrome (Posterior fossa malformations, large cervicofacial infantile Hemangiomas, Arterial anomalies, aortic coarctation and Cardiac abnormalities, and Eye abnormalities) is a neurocutaneous disorder including posterior fossa malformations, hemangiomas, arterial lesions, cardiac defects, and eye abnormalities. PHACE arteriopathies may be progressive and recently have been categorized based on the risk of acute ischemic stroke, increasing attention to the potentially devastating consequences of cerebrovascular complications in this syndrome. In contrast, the natural history of arteriopathy in PHACE syndrome remains poorly understood. At the moment, there are no established surgical guidelines for high-risk vasculopathies, including quasi-moyamoya, in this syndrome. CASE DESCRIPTION: We described the clinicoradiologic features of a small series of 6 patients with PHACE syndrome and quasi-moyamoya (5 female, age range 4 months to 12 years), focusing on the clinical course and surgical outcome of 3 children who were treated with encephaloduroarteriosynangiosis and encephalomyosynangiosis. In addition, we reviewed the radiologic, clinical, and surgical aspects of moyamoya vasculopathy in PHACE syndrome, providing information on 15 additional published cases.
CONCLUSIONS: Although the natural history of arteriopathy in PHACE syndrome is poorly understood, patients with high-risk vasculopathies, such as quasi-moyamoya disease, may benefit of revascularization by using encephaloduroarteriosynangiosis and encephalomyosynangiosis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain MRI; Encephaloduroarteriosynangiosis; Encephalomyosynangiosis; PHACE syndrome; Quasi-moyamoya disease

Mesh:

Year:  2017        PMID: 28887276     DOI: 10.1016/j.wneu.2017.08.176

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

1.  Moyamoya angiopathy in PHACE syndrome not associated with RNF213 variants.

Authors:  Jeffrie Hadisurya; Stephanie Guey; Lou Grangeon; Dagmar Wieczorek; Michaelle Corpechot; Jan Claudius Schwitalla; Markus Kraemer
Journal:  Childs Nerv Syst       Date:  2019-04-29       Impact factor: 1.475

2.  Two Cases of Oculofaciocardiodental (OFCD) Syndrome due to X-Linked BCOR Mutations Presenting with Infantile Hemangiomas: Phenotypic Overlap with PHACE Syndrome.

Authors:  T M Morgan; J M Colazo; L Duncan; R Hamid; K M Joos
Journal:  Case Rep Genet       Date:  2019-12-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.